Connect with us

Technology

Microfluidics Market to Reach US$ 43 Bn by 2031, Growing at 9.8% CAGR as Point-of-Care and Organ-on-Chip Adoption Expands: New Report by Wissen Research

Published

1 hour ago

on

SHERIDAN, Wyo., Sept. 28, 2026 /PRNewswire/ — The global microfluidics market is projected to grow from USD 26.9 billion in 2026 to USD 43 billion by 2031, registering a CAGR of 9.8% during the forecast period (2026–2031), according to a new study by Wissen Research.

Growth is being driven by rising demand for point-of-care testing and decentralized diagnostics, expanding use of precision medicine, and sustained pharmaceutical and biotech investment in organ-on-a-chip and droplet-based single-cell systems. Microfluidic platforms handle liquids at the microliter and nanoliter scale inside engineered channels, which cuts sample and reagent volumes, speeds up analysis, and moves testing closer to the patient, the research bench, and the field.

Get a Free Sample of This Report to Explore Key Findings and Data: https://www.wissenresearch.com/request-a-sample/?report=microfluidics-market

Where the Technology Is Heading: Integrated Chips, Smarter Readers

The most visible shift in microfluidics is the move from single-function chips, which run one test, to fully integrated sample-to-answer cartridges that combine sample preparation, amplification, and detection on a single chip. Manufacturers are extending chip integration into multifunctionality and coupling the hardware with AI-driven analysis software, allowing platforms once confined to specialized labs to operate in clinical and field environments.

Machine-learning algorithms are increasingly built into handheld and benchtop readers to analyze fluorescence, morphology, and other optical signals, supporting automated interpretation, quantitative output, and the standardized data capture and traceability that regulated diagnostic workflows require.

In pharmaceutical research, organ-on-a-chip models are gaining ground as a complement to conventional cell and animal-based models in early toxicity and efficacy testing. Multi-organ designs that link several tissue types on one platform are beginning to move from academic proof-of-concept into contract-research service offerings.

What’s Fueling Growth in the Microfluidics Market

Point-of-Care and Decentralized Diagnostics: Demand is rising for platforms that shorten the path between sample collection and clinical decision-making.Precision Medicine Expansion: Personalized medicine increasingly relies on high-throughput, low-volume molecular profiling that microfluidic platforms support cost-effectively.Pharma and Biotech R&D Investment: Sustained spending on organ-on-a-chip and droplet-based single-cell systems is broadening use in early-stage drug discovery.AI-Integrated Lab-on-Chip Analytics: Multiplexed on-chip assays and automated interpretation are widening the range of clinical and research use cases.Infrastructure Build-Out in Developing Economies: Rapid growth in diagnostic and life-science research infrastructure is opening new demand.Manufacturing Partnerships: Supply agreements between chip makers and diagnostic companies are easing production bottlenecks and shortening time to market.

Challenges Facing the Microfluidics Market

Cost and validation remain the main brakes on adoption. Microfluidic instrumentation carries high initial costs compared with conventional laboratory equipment, and validating new platforms adds further expense, which is particularly difficult for smaller research laboratories and cost-conscious institutions to absorb. Established laboratory procedures also resist change, even where a new format offers clear speed or volume advantages.

Regulation is another source of uncertainty. Frameworks continue to lag technology, especially for organ-chip platforms and multiplex diagnostics, and the treatment of formats designed to complement or reduce reliance on certain animal-based studies is still evolving. That makes long-range product planning harder for manufacturers. Some applications also still require trained personnel, specialized readers, and quality control procedures before clinical deployment.

Recent Strategic Developments in the Microfluidics Market

In August 2026, HyperMelt, a U.S. diagnostics startup, was reported to be developing a microfluidics-based platform that combines sample digitization with thermal analysis to improve molecular characterization of cancer-related biomarkers, with potential applications in early cancer detection and liquid biopsy workflows.

In April 2025, CEA-Leti and Infiplast of France launched a dedicated microfluidics initiative to accelerate the industrialization and manufacturing of healthcare-oriented microfluidic devices, helping move laboratory-developed technologies into commercial products.

In November 2024, Parallel Fluidics secured USD 7 million in seed funding to accelerate its microfluidic manufacturing platform for life science applications including IVF, biotechnology research, and advanced laboratory workflows.

Taken together, these moves point to an industry focused on scaling manufacturing, moving lab-built devices to market, and extending microfluidics into oncology and reproductive health.

Key Insights from Microfluidics Market Analysis

In vitro diagnostics dominates total consumption by application, spanning infectious disease panels, cardiac markers, and molecular point-of-care tests, while pharmaceutical and life sciences research is the rapidly growing segment, driven by proteomics, genomics, and organ-on-a-chip work.Consumables, including disposable chips, cartridges, and assay-specific products, represent a significant recurring-revenue segment, as they are replaced with each increase in testing volume, unlike capital-intensive instruments and readers.North America led the market in 2025, supported by established diagnostics and life science companies, a mature biotechnology ecosystem, deep R&D investment, and available venture capital.Asia-Pacific is the fastest-growing region, driven by diagnostics and research infrastructure investment, chronic and infectious disease prevalence, and government support for local microfluidic device manufacturing in China, India, and Japan.Competition runs on two models: diversified life-science companies offering integrated chip, instrument, consumable, and software workflows, and specialists focused on fabrication, organ-on-chip platforms, droplet generation, or flow control.

Key Players in the Microfluidics Market

Leading companies in the microfluidics market are focused on product innovation, lab-on-chip platform development, integration of microfluidics with molecular diagnostics and single-cell analysis, strategic collaborations, and manufacturing expansion.

Company

Key Focus Area

Thermo Fisher Scientific Inc. (US)

Life science instruments and consumables

Illumina, Inc. (US)

Sequencing and library preparation platforms

Bio-Rad Laboratories, Inc. (US)

Life science research and clinical diagnostics

Danaher Corporation (US)

Diagnostics and life sciences instrumentation

Agilent Technologies, Inc. (US)

Analytical instruments and life sciences tools

F. Hoffmann-La Roche Ltd (Switzerland)

Diagnostics platforms

bioMérieux (France)

Infectious disease diagnostics

Becton, Dickinson and Company (US)

Diagnostic instruments and consumables

Abbott Laboratories (US)

Diagnostics and point-of-care testing

10x Genomics (US)

Single-cell analysis platforms

Emulate (US)

Organ-on-chip technology

Dolomite Microfluidics (UK)

Droplet and microfluidic systems

Regional Analysis and Growth Opportunities

North America leads the microfluidics market, backed by a strong base of established diagnostics and life science companies, a mature biotechnology ecosystem, significant R&D investment, and a dense network of device manufacturers, component suppliers, and research institutions across major biotech clusters. The region’s experience with regulatory pathways for diagnostic technologies further supports commercialization and adoption.

Asia-Pacific is the fastest-growing region, with rising investment in diagnostics and research infrastructure, a growing burden of chronic and infectious disease, and government support for local manufacturing of microfluidic devices. Growing R&D spending and cross-border manufacturing collaborations in China, India, and Japan are positioning the region as an important contributor to global demand.

Europe, Latin America, and the Middle East & Africa complete the report’s regional coverage, with growth shaped by expanding diagnostic capacity and rising research investment.

Get a Custom Briefing on This Market for Your Business

Wissen Research’s technology analysts are available to walk through findings specific to your market, region, or competitive set.

Need Insights Specific to Your Business? Request a Customized Version of This Report: https://www.wissenresearch.com/request-customization/?report=microfluidics-market

Market Segmentation Snapshot

The global microfluidics market is segmented across product type, material, technology, application, end user, and region:

By Product Type: Microfluidic-Based Devices (Lab-on-a-Chip, Organ-on-a-Chip, Microfluidic PCR Platforms, Capillary Electrophoresis Systems, NGS Library Preparation Platforms, Droplet & Particle Production Systems)Microfluidic Components (Chips, Flow & Pressure Sensors, Flow & Pressure Controllers, Valves, Micropumps, Microneedles)By Material: SiliconGlassPolymer Materials (PDMS, PMMA, COC, Others)Paper & Other Porous SubstratesOther MaterialsBy Technology: Continuous-Flow MicrofluidicsDigital/Droplet MicrofluidicsOrgan-on-Chip & Tissue-Chip TechnologyElectrophoretic MicrofluidicsOptofluidicsAcoustofluidics & ElectrowettingCentrifugal MicrofluidicsPaper-Based MicrofluidicsBy Application: In Vitro Diagnostics (Clinical Diagnostics, Point-of-Care Testing, Veterinary Diagnostics)Pharmaceutical & Life Science ResearchTherapeutics (Drug Delivery, Wearable Therapeutic & Monitoring Devices)Environmental & Food Safety TestingOther ApplicationsBy End User: Hospitals & Diagnostic Centers/LaboratoriesPharmaceutical & Biotechnology CompaniesAcademic & Research InstitutesCROs/CMOsForensic & Environmental Testing LaboratoriesOthersBy Region: North AmericaEuropeAsia-PacificLatin AmericaMiddle East & Africa

Frequently Asked Questions

Q: What is the size of the microfluidics market? 

A: The global microfluidics market is estimated at USD 26.9 billion in 2026 and is projected to reach USD 43 billion by 2031.

Q: What is the growth rate of the microfluidics market? 

A: The microfluidics market is projected to grow at a CAGR of 9.8% between 2026 and 2031.

Q: Which application dominates the microfluidics market? 

A: In vitro diagnostics dominates total consumption, covering infectious disease panels, cardiac markers, and molecular point-of-care tests, while pharmaceutical and life sciences research is the fastest-growing application segment.

Q: Which region leads the microfluidics market? 

A: North America led the microfluidics market in 2025, while Asia-Pacific is the fastest-growing region through 2031.

Q: What is organ-on-a-chip technology? 

A: Organ-on-a-chip devices use microfluidic channels to mimic the mechanical and biochemical conditions of specific human tissues, and pharmaceutical companies use them in early toxicity and efficacy testing to complement conventional cell culture and animal-based models.

Q: Who are the top players in the microfluidics market? 

A: Leading players in the microfluidics market include Thermo Fisher Scientific Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, and Agilent Technologies, Inc.

As integrated sample-to-answer cartridges, AI-enabled analytics, and organ-on-a-chip models continue to mature, microfluidics is becoming a core enabling technology across diagnostics, drug discovery, and life science research. For manufacturers, the path forward lies in scalable production, regulatory readiness, and platforms that lower the cost of moving from laboratory to point of care.

Get the Complete Microfluidics Market Report — Forecasts, Insights & Growth Opportunities: https://www.wissenresearch.com/market-research-reports-pricings/microfluidics-market

Expert Profile | Mayur Jain, Wissen Research 

Mayur Jain is a Research Expert at Wissen Research with multidomain expertise with more than 12+ years of experience in market research industry. 

Email: mayur@wissenresearch.com
LinkedIn:  https://www.linkedin.com/in/mayur-jain-0190542a/ 

About Wissen Research

Wissen Research is a global market intelligence and consulting firm specializing in healthcare, life sciences, technology, and emerging industries. The company provides data-driven insights, strategic market analysis, and industry forecasts to help organizations make informed business decisions and identify new growth opportunities across global markets

Company Contact:

Wissen Research LLC,
Gould St, Ste R,
Sheridan, WY 82801,
Phone: (+1) 510 240 9853
Email: info@wissenresearch.com
Website: https://www.wissenresearch.com/
Blog: https://www.wissenresearch.com/insights/
LinkedIn: https://www.linkedin.com/company/wissen-research 

 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/microfluidics-market-to-reach-us-43-bn-by-2031–growing-at-9-8-cagr-as-point-of-care-and-organ-on-chip-adoption-expands-new-report-by-wissen-research-302891528.html

Related Topics:
Continue Reading

Technology

Gastops FluidSIGHT™ Selected for Royal Canadian Navy Evaluation Through Innovative Solutions Canada

Published

21 minutes ago

on

September 28, 2026

By

OTTAWA, ON, Sept. 28, 2026 /PRNewswire/ — Gastops, a leader in intelligent condition monitoring and predictive maintenance solutions, has been awarded a contract under the Government of Canada’s Innovative Solutions Canada (ISC) Testing Stream program.

Through the project, FluidSIGHT™ will be demonstrated and evaluated in collaboration with the Department of National Defence (DND) to support ongoing efforts to advance condition-based and predictive maintenance capabilities within the Royal Canadian Navy.

As part of the project, Gastops will deliver FluidSIGHT™ systems, software, training, installation support, and technical expertise to support testing and evaluation activities. Testing will take place across multiple operational and laboratory environments, including facilities in Ottawa and Montreal, as well as aboard marine vessels operating in Atlantic Canada.

FluidSIGHT™ is a real-time oil condition, contamination, and wear monitoring system that provides continuous visibility into lubricant health. By moving beyond periodic oil sampling and laboratory testing, the system helps operators make more intelligent maintenance decisions based on real-time equipment condition.

The project is an important milestone for FluidSIGHT™ following its launch earlier this year and will support evaluation of the technology across a range of operational and laboratory environments. Testing will assess the system’s ability to accurately monitor lubricant health and provide real-time insight into equipment condition.

“This project represents the next step in FluidSIGHT’s evolution from innovation to real-world application,” said Shaun Horning, President & CEO of Gastops. “For more than four decades, Gastops has helped maintainers make informed decisions through equipment health intelligence. We are proud to work alongside the Government of Canada and the Department of National Defence to demonstrate how real-time condition awareness can contribute to readiness, availability, and more efficient sustainment practices.”

The project aligns with DND’s interest in transitioning from traditional schedule-based maintenance toward more efficient condition-based and predictive maintenance approaches that improve materiel availability, support data-driven decision-making, and enhance operational readiness.

“Maintenance teams have more data available than ever before, but what matters is turning that data into action,” said Brennan West, Vice President, Energy, Marine & Land at Gastops. “FluidSIGHT provides real-time visibility into equipment condition, helping maintainers identify issues earlier, better understand asset health, and make more informed decisions that improve availability and support readiness.”

Gastops will be exhibiting at DEFSEC Atlantic 2026 in Halifax, Nova Scotia from October 6-8. Attendees are invited to visit the team at Booth B107 to learn more about FluidSIGHT™ and other Gastops technologies supporting equipment health intelligence, predictive maintenance, and operational readiness.

About Gastops

Gastops is the world’s leading provider of intelligent condition monitoring solutions used in Aerospace, Defence, Energy, and Industrial applications to optimize the availability, performance, and safety of critical assets. We offer peace of mind to our customers with innovative online monitoring sensors, at-line analysis, complex modeling and simulation, world-class laboratory testing, engineering, design, and MRO services that predict performance to enable proactive operating decisions. We have been providing powerful insights into the condition of critical equipment since 1979. Gastops is the intelligence inside what moves you.

View original content:https://www.prnewswire.com/news-releases/gastops-fluidsight-selected-for-royal-canadian-navy-evaluation-through-innovative-solutions-canada-302888688.html

SOURCE Gastops Ltd.

Continue Reading

Technology

GBC Introduces an Evolved Brand Built on an Enduring Purpose

Published

21 minutes ago

on

September 28, 2026

By

HOUSTON, Sept. 28, 2026 /PRNewswire/ — Over the past several years, GBC (formerly GB Connections) has grown in meaningful ways. The company has expanded its leadership team, strengthened its engineering capabilities and built the systems needed to support long-term growth. Along the way, GBC has become more intentional about who it is, how it creates value and where it is headed next.

Today, GBC is introducing an evolved brand that reflects these intentions. It includes an updated logo, visual identity and story as well as a simpler approach to the company’s name: going forward, GBC will become the primary way the company represents itself.

The name GBC carries forward the company’s history in connections while reflecting how it has evolved. For GBC, the name means Generating Better Connections. That starts with the connection solutions the company engineers but extends beyond its products. It reflects the way GBC connects engineering intent with governed execution, brings together the people, partners and capabilities required to deliver reliably and builds strong relationships with the customers and partners it serves.

“Generating Better Connections reflects what we do at every level of the business,” said Robert L. Kovar, P.E., President and Chief Executive Officer of GBC. “We engineer connection solutions, connect engineering intent with disciplined execution and build strong relationships that help us understand and respond as customer needs evolve. The name is a natural expression of who we are today and how we create value.”

A Brand Designed to Express GBC’s Purpose

Last year, GBC invested in defining its purpose, vision, mission, values and behaviors. The company’s purpose, to energize progress, has become the cornerstone of its brand. Every element of the new brand has been developed to better express that purpose and the role GBC plays in helping customers move forward.

The company’s visual identity carries the same intention. The logo’s arrow motif symbolizes forward momentum, while subtle references to thread forms honor the products and engineering heritage that have defined the business for more than three decades. Bold typography, vibrant colors and dynamic graphics reinforce a sense of energy, clarity and progress.

GBC’s story has evolved as well. It now more clearly reflects how the company creates value: bringing engineering expertise, governed execution and agility together to help remove the constraints that slow advancement and helping customers move forward with greater clarity, confidence and capability.

Looking Ahead

Over the coming months, the evolved GBC identity and story will appear across the company’s technical literature, marketing materials and communications. Later this year, GBC will launch a redesigned website that more fully brings the new brand to life.

The way GBC represents itself is evolving, but the standards, relationships and commitments behind the company remain firmly rooted in who it is.

The evolved GBC brand provides a stronger foundation for the company’s continued growth while giving clearer expression to the purpose, capabilities and commitments that have long defined the business. As the new identity rolls out, GBC will continue applying that same focus to the solutions it develops, the partnerships it builds and the ways it helps customers move forward.

About GBC

GBC is an independent engineering authority specializing in OCTG connection solutions for demanding drilling and production environments. GBC designs, qualifies and oversees manufacturing through trusted partners, helping operators, engineers and distributors identify right-fit solutions supported by disciplined engineering, governed execution and responsive partnership. As technical, operational and commercial conditions evolve, GBC helps customers move forward with greater clarity, confidence and capability.

Learn more at www.gbconnections.com 

Contact
Chad Gorball press@gbconnections.com (713) 465-3585

View original content to download multimedia:https://www.prnewswire.com/news-releases/gbc-introduces-an-evolved-brand-built-on-an-enduring-purpose-302891474.html

SOURCE GB Connections LLC

Continue Reading

Technology

Optima Academy Online Outpaces National i-Ready Growth Benchmarks in Reading and Math

Published

21 minutes ago

on

September 28, 2026

By

Optima Academy Online (OAO) announced that its students exceeded i-Ready’s national Typical Growth benchmarks in both reading and math for the 2025–26 school year. School-wide median progress reached 120% of Typical Growth in reading and 104% in math, with additional students meeting i-Ready’s more ambitious Stretch Growth targets. The results build on OAO’s prior-year performance and reflect continued academic growth across kindergarten through eighth grade.

NAPLES, Fla., Sept. 28, 2026 /PRNewswire-PRWeb/ — Optima Academy Online (OAO), a fully virtual, Cognia-accredited school, today announced its assessed students exceeded i-Ready’s annual Typical Growth benchmark at the school-wide median in both reading and math for 2025–26. Median progress reached 120% of the growth target in reading and 104% in math, placing OAO above the 100% benchmark in both subjects.

i-Ready’s Typical Growth measure provides a national research-based reference for average annual academic growth among students who begin at similar levels of proficiency. Developed by Curriculum Associates using multiyear research on millions of i-Ready users, the growth model accounts for students’ starting performance. It gives families a way to understand academic progress in relation to an established benchmark beyond the school itself.

At 120% of Typical Growth, OAO’s median reading progress was 20% above the annual target. In math, median progress was 4% above the target. These results show that the school-wide median surpassed the full annual Typical Growth target in both core subjects.

“Seeing our students exceed i-Ready’s growth benchmarks in both reading and math is exciting, and we couldn’t be prouder of their progress,” said Adam Mangana, CEO of Optima. “Our approach brings a classical foundation in knowledge and virtue together with the science of how children learn. Caring, certified teachers bring that foundation to life through immersive experiences, using VR and AI to help students explore ideas and connect with one another. These results are an encouraging milestone in our commitment to making learning engaging, purposeful, and academically strong.”

These results also show students reaching i-Ready’s more ambitious Stretch Growth targets, which are designed to support progress toward grade-level proficiency. In 2025–26, 38% of assessed students met Stretch Growth in reading and 35% did so in math.

Benchmark results build on improvements from the prior school year, when OAO’s median progress reached 100% of Typical Growth in both subjects.

Findings come from OAO’s most recent 2026 i-Ready Diagnostic summary for kindergarten through eighth grade, using the latest 2025–26 assessment available in that report.

About Optima Academy Online

Optima Academy Online is a fully virtual, classically aligned, and Cognia-accredited school offering teacher-led and self-guided instruction. Its parent company, Optima, blends a liberal arts foundation with immersive VR and AI-powered technology to help students learn more deeply and educators teach more effectively. Optima partners with independent schools, public school districts, microschools, and home learners nationwide. For more information, visit optimaxr.ai and optimaacademy.online.

Media Contact

Bridgette Jensen, Optima, 1 2394498599, marketing@optimaed.com, optimaxr.ai

Twitter, LinkedIn

View original content to download multimedia:https://www.prweb.com/releases/optima-academy-online-outpaces-national-i-ready-growth-benchmarks-in-reading-and-math-302890757.html

SOURCE Optima

Continue Reading

Trending